13F
中

CSBR CHAMPIONS ONCOLOGY INC

2026Q1 · CUSIP 15870P307 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
24
Δ holders QoQ
-3
Breadth percentile
n/a
Whale holders
9
Δ whales
-1
Inst. holding value
$33M
New positions
4
Closed positions
7
Price momentum (1Q)
—
Put / Call
1/0

Breadth history (34 quarters)

2018Q1: Δ+0 · h=14 2018Q2: Δ+4 · h=18 2018Q3: Δ+20 · h=38 2018Q4: Δ+8 · h=46 2019Q1: Δ-7 · h=39 2019Q2: Δ+0 · h=39 2019Q3: Δ-4 · h=35 2019Q4: Δ+0 · h=35 2020Q1: Δ-1 · h=34 2020Q2: Δ+13 · h=47 2020Q3: Δ+1 · h=48 2020Q4: Δ+1 · h=49 2021Q1: Δ-2 · h=47 2021Q2: Δ-7 · h=40 2021Q3: Δ-4 · h=36 2021Q4: Δ-4 · h=32 2022Q1: Δ-1 · h=31 2022Q2: Δ+2 · h=33 2022Q3: Δ+0 · h=33 2022Q4: Δ-3 · h=30 2023Q1: Δ+1 · h=31 2023Q2: Δ-2 · h=29 2023Q3: Δ+1 · h=30 2023Q4: Δ-6 · h=24 2024Q1: Δ+1 · h=25 2024Q2: Δ-2 · h=23 2024Q3: Δ+0 · h=23 2024Q4: Δ+2 · h=25 2025Q1: Δ+10 · h=35 2025Q2: Δ-3 · h=32 2025Q3: Δ-5 · h=27 2025Q4: Δ+0 · h=27 2026Q1: Δ-3 · h=24 2018Q1: holders=14 2018Q2: holders=18 2018Q3: holders=38 2018Q4: holders=46 2019Q1: holders=39 2019Q2: holders=39 2019Q3: holders=35 2019Q4: holders=35 2020Q1: holders=34 2020Q2: holders=47 2020Q3: holders=48 2020Q4: holders=49 2021Q1: holders=47 2021Q2: holders=40 2021Q3: holders=36 2021Q4: holders=32 2022Q1: holders=31 2022Q2: holders=33 2022Q3: holders=33 2022Q4: holders=30 2023Q1: holders=31 2023Q2: holders=29 2023Q3: holders=30 2023Q4: holders=24 2024Q1: holders=25 2024Q2: holders=23 2024Q3: holders=23 2024Q4: holders=25 2025Q1: holders=35 2025Q2: holders=32 2025Q3: holders=27 2025Q4: holders=27 2026Q1: holders=24 -20 -10 +0 +10 +20 123252 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2018Q3 Top 10% -31.0% -31.8%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.15
EPS YoY
-134.1%
Revenue (TTM)
$0.1B
Revenue YoY
-1.1%
Quarterly Revenue & EPS (4Y)
2022-04-30: $13M 2022-07-31: $14M 2022-10-31: $14M 2023-01-31: $13M 2023-04-30: $13M 2023-07-31: $13M 2023-10-31: $12M 2024-01-31: $12M 2024-04-30: $14M 2024-07-31: $14M 2024-10-31: $13M 2025-01-31: $17M 2025-04-30: $12M 2025-07-31: $14M 2025-10-31: $15M 2026-01-31: $17M 2022-04-30: EPS -0.02 2022-07-31: EPS -0.02 2022-10-31: EPS 0.00 2023-01-31: EPS -0.18 2023-04-30: EPS -0.19 2023-07-31: EPS -0.19 2023-10-31: EPS -0.15 2024-01-31: EPS -0.19 2024-04-30: EPS -0.01 2024-07-31: EPS 0.09 2024-10-31: EPS 0.05 2025-01-31: EPS 0.31 2025-04-30: EPS -0.12 2025-07-31: EPS -0.03 2025-10-31: EPS 0.02 2026-01-31: EPS -0.02 0M 9M 17M $M -0.21 0.07 0.34 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 33 2025-01-31: PE 23.12025-04-30: PE 23.12025-07-31: PE 33.22025-10-31: PE 35.1 21 29 37 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-01-31 · SEC filings (XBRL)